首页> 外文会议>Conference on Skeletal Biology and Medicine >Selecting Patients for Osteoporosis Therapy
【24h】

Selecting Patients for Osteoporosis Therapy

机译:选择骨质疏松症治疗患者

获取原文

摘要

Our goal globally is to better identify individuals at risk for osteoporotic fracture so that those at high risk can be treated and unnecessary treatment for those at low risk can be avoided. Bone mineral density (BMD) information is not sufficient to identify all patients at high risk. Approximately half of patients in the community with fractures do not have osteoporosis by the 1994 World Health Organization BMD criteria. Furthermore, BMD information based on central DXA is not easily accessible worldwide. The use of clinical risk factors with or without BMD information will improve gradient of risk and help us better identify patients at high risk for fracture. The clinical risk factors identified can be integrated to predict a 10-year absolute risk or probability of fracture. Intervention thresholds based on absolute risk will be defined regionally based on each nation's ability and willingness to pay.
机译:全球目标是更好地识别骨质疏松骨折风险的个体,以便可以避免对高风险的人进行治疗,并且可以避免低风险的治疗。骨矿物密度(BMD)信息不足以识别高风险的所有患者。 1994年世界卫生组织BMD标准,社区中大约一半的患者骨折无骨质疏松症。此外,基于Central DXA的BMD信息不容易遍布全球。使用或不具有BMD信息的临床风险因素将提高风险的梯度,并帮助我们更好地识别骨折高风险的患者。确定的临床风险因素可以集成以预测10年的绝对风险或骨折概率。基于绝对风险的干预阈值将基于每个国家的能力和支付愿意来定义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号